Perfusion circuit concepts for hollow-fiber bioreactors used as in vitro cell production systems or ex vivo bioartificial organs

International Journal of Artificial Organs

Volumn 34, Issue 5, 2011, Pages 410-421

  Balmert, Stephen C ^a   McKeel, Daniel ^a   Triolo, Fabio ^b   Gridelli, Bruno ^b   Zeilinger, Katrin ^c   Bornemann, Reiner ^d   Gerlach, Jörg C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Stem Cell Systems   (Germany)

Author keywords

Bioartificial liver; Bioreactors; Hematopoietic stem cells; Perfusion circuit; Perfusion pressure; Volume shifts

Indexed keywords

ARTIFICIAL ORGANS; BIOCONVERSION; CYTOLOGY; ELECTRIC NETWORK ANALYSIS; STEM CELLS; TIMING CIRCUITS;

BIOARTIFICIAL LIVER; CELL PRODUCTION SYSTEM; CIRCUIT CONFIGURATIONS; HAEMATOPOIETIC STEM CELLS; HOLLOW FIBER BIOREACTOR; IN-VITRO; PERFUSION CIRCUIT; PERFUSION PRESSURE; VITRO CELL; VOLUME SHIFT;

BIOREACTORS;

ARTICLE; BIOARTIFICIAL ORGAN; DEVICE; HOLLOW FIBER REACTOR; PERFUSION; PRESSURE MEASUREMENT; REGENERATIVE MEDICINE;

EID: 79959283243     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/IJAO.2011.8366     Document Type: Article

References (33)

1. Powell K. Stem-cell niches: it's the ecology, stupid! Nature 2005; 435: 268-70. Medline. doi:10.1038/435268a
2. Cukierman E, Pankov R, Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002; 14: 633-9 Medline. doi:10.1016/S0955-0674(02)00364-2
3. Abbott A. Cell culture: biology's new dimension. Nature. 2003; 424: 870-2. Medline. doi:10.1038/424870a
4. Gerlach JC, Mutig K, Sauer IM, et al. Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study. Transplantation 2003; 76: 781-6. Medline. doi:10.1097/01.TP.0000083319.36931.32
5. Monga SP, Hout MS, Baun MJ, et al. Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors. Am J Pathol 2005; 167: 1279-92.
6. Xu AS, Reid LM. Lineage biology and liver. In: Lanza RP, Langer R, Vacanti J, eds. Principles of Tissue Engineering. San Diego, CA: Academic Press 1999: 559-98.
7. Catapano G, Gerlach JC. Bioreactors for Liver Tissue Engineering. In: Ashammakhi N, Reis R, Chiellini E, eds. Topics in Tissue Engineering 2007; 8: 1-42.
8. Abbot S, Zhang X, Kang L, et al. Blood pharming: Automated in vitro erythrocyte production. Poster presented at: Advanced Technology Applications for Combat Casualty Care Conference; 2009 Aug 10-12; St. Petersburg Beach, FL.
9. Gerlach J, Zeilinger K, Sauer IM, et al. Extracorporeal liver support: Porcine or human cell based systems? Int J Artif Organs 2002; 25 (10): 1013-8.
10. Gerlach JC. Bioreactors for Extracorporeal Liver Support. Cell Transplant 2006; 15 (1): 1-12 Medline. doi:10.3727/000000006783982296
11. Rozga J, Holzmann MD, Ro MS, et al. Development of a hybrid bioartificial liver. Ann Surg. 1993;217(5):502-509; discussion 509-511. Medline. doi:10.1097/00000658-199305010-00010
12. Nyberg SL, Russel A, Shatford RA, et al. Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng 1993; 41: 194-203. Medline. doi:10.1002/bit.260410205
13. Sussman NL, Chong MG, Koussayer T, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16 (1): 60-5. doi: 10.1002/hep.1840160112
14. Gerlach J, Jörres A, Trost O, et al. Side effects of hybrid liver support therapy: TNF-α liberation in pigs, associated with extracorporeal bioreactors. Int J Artif Organs 1993; 16 (8): 604-8.
15. Gerlach J, Trost T, Ryan CJ, et al. Hybrid liver support system in a short term application on hepatectomized pigs. Int J Artif Organs 1994; 17 (10): 549-55.
16. Janke J, Gerlach J, Kardassis D, Böhmer C, Rossaint R. Effect of a hybrid liver support system on cardiopulmonary function in healthy pigs. Int J Artif Organs 1997; 20 (10): 570-5.
17. Gerlach JC, Zeilinger K, Patzer JF II. Bioartificial liver systems: why, what, whither? Regen Med 2008; 3: 575-95 Medline. doi:10.2217/17460751.3.4.575
18. Timmins NE, Nielsen LK. Blood cell manufacture: current methods and future challenges. Trends Biotechnol 2009; 27 (7): 415-22. Medline. doi:10.1016/j.tibtech.2009.03.008
19. Chen X, Xu H, Wan C, McCaigue M, Li G. Bioreactor expansion of human adult bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24: 2052-9 Medline. doi:10.1634/stemcells.2005-0591
20. Conrad V, Bordenave L, Rouais F, et al. Ex vivo expansion of haematopoietic progenitors on an endothelialized hydroxyapatite matrix. J Mater Sci Mater Med 1997; 8: 819-22 Medline. doi:10.1023/A:1018585201309
21. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005; 23: 69-74. Medline. doi:10.1038/nbt1047
22. Neildez-Nguyen TMA, Wajcman H, Marden MC, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002; 20: 467-72 Medline. doi:10.1038/nbt0502-467
23. Fong WJ, Tan HL, Choo A, Oh SK. Perfusion cultures of human embryonic stem cells. Bioprocess Biosyst Eng 2005; 27 (6): 381-7.
24. Ouyang A, Yang ST. A two-stage perfusion fibrous bed bioreactor system for mass production of embryonic stem cells. Expert Opin Biol Ther 2008; 8 (7): 895-909. Medline. doi:10.1517/14712598.8.7.895
25. Williams C, Wakeman R. Membrane fouling and alternative techniques for its alleviation. Membr Technol 2000; 2000 (124): 4-10.
26. Rosenson RS, McCormick A, Uretz EF. Distribution of blood viscosity values and biochemical correlates in healthy adults. Clin Chem 1996; 42: 1189-95.
27. Mundt A, Puhl G, Müller A, et al. A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver support. Int J Artif Organs 2002; 25 (6): 542-8.
28. Fuchs M, Gerlach J, Unger J, et al. Alpha-keto acid metabolism by hepatocytes cultured in a hybrid liver support bioreactor. Int J Artif Organs 1994; 17 (10): 554-8.
29. Fuchs M, Gerlach J, Unger J, et al. Amino acid metabolism by hepatocytes in a hybrid liver support bioreactor. Int J Artif Organs 1994; 17 (12): 663-9.
30. Pless G, Steffen I, Zeilinger K, et al. Evaluation of primary human liver cells in bioreactor cultures for extracorporeal liver support on the basis of urea production. Artif Organs 2006; 30 (9): 686-94. Medline. doi:10.1111/j.1525-1594.2006.00285.x
31. Gerlach JC, Brayfield C, Puhl G, et al. Lidocaine/monoethylglycinexylidide test, galactose elimination test, and sorbitol elimination test for metabolic assessment of liver cell bioreactors. Artif Organs 2010; 34 (6): 462-72. Medline. doi:10.1111/j.1525-1594.2009.00885.x
32. Sauer IM, Kardassis D, Zeilinger K, et al. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Xenotransplantation 2003; 10 (5): 460-9. Medline. doi:10.1034/j.1399-3089.2003.00062.x
33. Gerlach JC, Mutig K, Zeilinger K, et al. Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study. Transplantation 2003; 76 (5): 781-6. Medline. doi:10.1097/01.TP.0000083319.36931.32